Key result
DSE identifies myocardial viability with ~88% sensitivity compared to 18F-FDG PET.
Why the study?
Myocardial viability assessment is important for revascularization decisions in coronary artery disease with LV dysfunction, but comparative accuracy data between DSE and 18F-FDG PET are needed.
Does dobutamine stress echocardiography accurately identify viable myocardium compared to 18F-FDG PET in patients with ischemic cardiomyopathy?
Observational
No
Does dobutamine stress echocardiography accurately identify viable myocardium compared to 18F-FDG PET in patients with ischemic cardiomyopathy?
Dobutamine stress echocardiography is a highly specific and moderately sensitive alternative to 18F-FDG PET for assessing myocardial viability in patients with ischemic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
May support dobutamine echocardiography as specific alternative to PET; leaves open prospective outcome validation in ischemic cardiomyopathy.
Background: Myocardial viability is utilized in the decision-making process for suitability of revascularization in patients with coronary artery disease and depressed left ventricular (LV) function. Aims: The aim of this study was to compare the accuracy of dobutamine stress echocardiography (DSE) with the 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) for the identification of viable myocardium in patients with previous myocardial infarction and LV dysfunction. Settings and Design: This was a prospective observational study done at Nizam’s Institute of Medical Sciences. Materials and Methods: Patients with coronary artery disease with previous myocardial infarction with significant LV dysfunction were included in the study. Statistical Analysis: Categorical variables were presented in number and percentage (%), and continuous variables were presented as mean ± standard deviation. Student’s paired t -test was applied to test the difference between the outcomes of 18F-FDG PET and dobutamine stress echo. The statistical software SPSS 17.0 version was used in the analysis of the data. Results: In our study population, the mean LV ejection fraction was 35.1%. A total of 800 myocardial segments were evaluated with resting two-dimensional echocardiography examination, of which 250 (31.2%) were normal and 550 (68.8%) were abnormal segments. The dysfunctional 550 segments were further assessed with DSE followed by 18F-FDG PET. In our study, 453 segments were viable on 18F-FDG PET and 407 segments viable on DSE ( P = 0.001). Viability was detected by both modalities in 88.1% and discordance in 11.9% of segments. These results yielded a positive predictive value of 97.8% and negative predictive value of 61.1% of DSE. Conclusions: On considering 18F-FDG PET a gold standard for detection of viable myocardial segments, DSE has shown a sensitivity of 87.6% and specificity of 90.7%. Thus, DSE can be used as a good alternate to 18F-FDG PET where facility for FDG PET is not available. However, patients detected to have nonviable dysfunctional segments on DSE can be evaluated further with 18F-FDG PET for confirmation of viability.
No takes yet. Share an insight, caveat, or question.
Kumari et al. (2024) conducted an observational in Coronary artery disease with previous myocardial infarction and significant LV dysfunction. Dobutamine stress echocardiography (DSE) vs. 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) was evaluated on Identification of viable myocardium in dysfunctional segments (p=0.001). Dobutamine stress echocardiography detected viability in 74.0% of dysfunctional segments compared to 82.4% by 18F-FDG PET, demonstrating 87.6% sensitivity and 90.7% specificity.
Synapse has enriched 10 related papers. Consider them for comparative context: